1.Microbial Culture Results and Pathogen Profiles of Donor Corneas in Eye Bank
Jianping JI ; Huicong HU ; Zhancong OU ; Rongrong CHEN ; Jiabi LIANG ; Nandan WU ; Xiaojuan DONG ; Ting HUANG
Journal of Sun Yat-sen University(Medical Sciences) 2026;47(5):886-898
ObjectiveTo analyze the microbial culture positivity rate, pathogen spectrum, prevalence of multidrug-resistant organisms (MDROs), and differences among donor procurement sources in corneas from the Eye Bank of Guangdong Province, and to provide evidence for eye bank quality control and the prevention of post-keratoplasty infections. MethodsThis retrospective study included 7 442 donor corneas procured by the Eye Bank of Guangdong Province and used for keratoplasty at Zhongshan Ophthalmic Center, Sun Yat-sen University, between 2018 and 2025. During surgery, donor corneoscleral rim tissue was excised for bacterial and fungal culture. Culture-positive specimens underwent microbial identification and antimicrobial susceptibility testing (AST). Culture-positive corneas were compared across study years, pathogen categories, and donor procurement sources. ResultsOf the 7 442 donor corneas, 251 were culture-positive, corresponding to an overall culture positivity rate of 3.37%, with annual rates ranging from 1.50% to 5.31%. Among culture-positive corneas, 178 (70.92%) yielded bacteria alone, 72 (28.68%) yielded fungi alone, and 1 (0.40%) yielded both bacteria and fungi. Candida spp. and Aspergillus spp. were the predominant fungal isolates. Gram-negative bacteria were more frequently isolated than Gram-positive bacteria. The most common bacterial isolates were Acinetobacter baumannii, Staphylococcus epidermidis, Stenotrophomonas maltophilia, Enterococcus faecium, and Pseudomonas fluorescens. MDROs accounted for 75.47% of bacterial isolates, predominantly Acinetobacter baumannii, Staphylococcus epidermidis, and Enterococcus faecium, and demonstrated an increasing trend over the study period. Donor corneas procured through the Hospital Cornea Retrieval Program (HCRP) had a higher culture positivity rate than those obtained through Organ Procurement Organization (OPO) (P<0.000 1). Among culture-positive donor corneas, the proportion of fungal culture-positive corneas was significantly higher in the HCRP group than in the OPO group (P=0.001 5), whereas the proportion of MDROs among bacterial culture-positive corneas was significantly higher in the OPO group than that in the HCRP group (P=0.005 2). ConclusionsThe overall culture positivity rate of donor corneas from the Eye Bank of Guangdong Province is relatively low, indicating that the risk of microbial contamination is controlled. However, pathogen profiles and antimicrobial resistance patterns varies by procurement source. Ongoing microbiological and antimicrobial resistance surveillance, together with optimized donor risk assessment and timely reporting of culture results, may further improve eye bank quality management and help inform strategies for preventing post-keratoplasty infections.
2.Microbial Culture Results and Pathogen Profiles of Donor Corneas in Eye Bank
Jianping JI ; Huicong HU ; Zhancong OU ; Rongrong CHEN ; Jiabi LIANG ; Nandan WU ; Xiaojuan DONG ; Ting HUANG
Journal of Sun Yat-sen University(Medical Sciences) 2026;47(5):886-898
ObjectiveTo analyze the microbial culture positivity rate, pathogen spectrum, prevalence of multidrug-resistant organisms (MDROs), and differences among donor procurement sources in corneas from the Eye Bank of Guangdong Province, and to provide evidence for eye bank quality control and the prevention of post-keratoplasty infections. MethodsThis retrospective study included 7 442 donor corneas procured by the Eye Bank of Guangdong Province and used for keratoplasty at Zhongshan Ophthalmic Center, Sun Yat-sen University, between 2018 and 2025. During surgery, donor corneoscleral rim tissue was excised for bacterial and fungal culture. Culture-positive specimens underwent microbial identification and antimicrobial susceptibility testing (AST). Culture-positive corneas were compared across study years, pathogen categories, and donor procurement sources. ResultsOf the 7 442 donor corneas, 251 were culture-positive, corresponding to an overall culture positivity rate of 3.37%, with annual rates ranging from 1.50% to 5.31%. Among culture-positive corneas, 178 (70.92%) yielded bacteria alone, 72 (28.68%) yielded fungi alone, and 1 (0.40%) yielded both bacteria and fungi. Candida spp. and Aspergillus spp. were the predominant fungal isolates. Gram-negative bacteria were more frequently isolated than Gram-positive bacteria. The most common bacterial isolates were Acinetobacter baumannii, Staphylococcus epidermidis, Stenotrophomonas maltophilia, Enterococcus faecium, and Pseudomonas fluorescens. MDROs accounted for 75.47% of bacterial isolates, predominantly Acinetobacter baumannii, Staphylococcus epidermidis, and Enterococcus faecium, and demonstrated an increasing trend over the study period. Donor corneas procured through the Hospital Cornea Retrieval Program (HCRP) had a higher culture positivity rate than those obtained through Organ Procurement Organization (OPO) (P<0.000 1). Among culture-positive donor corneas, the proportion of fungal culture-positive corneas was significantly higher in the HCRP group than in the OPO group (P=0.001 5), whereas the proportion of MDROs among bacterial culture-positive corneas was significantly higher in the OPO group than that in the HCRP group (P=0.005 2). ConclusionsThe overall culture positivity rate of donor corneas from the Eye Bank of Guangdong Province is relatively low, indicating that the risk of microbial contamination is controlled. However, pathogen profiles and antimicrobial resistance patterns varies by procurement source. Ongoing microbiological and antimicrobial resistance surveillance, together with optimized donor risk assessment and timely reporting of culture results, may further improve eye bank quality management and help inform strategies for preventing post-keratoplasty infections.
3.Rauch-Steindl Syndrome Caused by NSD2 Mutation:A Case Report and Follow-up of Growth Hormone Therapy
Qun ZENG ; Siqi HUANG ; Hui OU ; Xiaojuan LI ; Liyang LIANG
Journal of Sun Yat-sen University(Medical Sciences) 2025;46(4):714-720
[Objective]To analyze the clinical characteristics,efficacy of growth hormone(GH)therapy,and follow-up of a child with Rauch-Steindl syndrome(RAUST)caused by NSD2 gene mutation,aiming to enhance pediatricians'understanding of this disorder.[Methods]We summarized the clinical features,gene test results,outcomes of GH therapy,and follow-up data of a child with RAUST syndrome caused by NSD2 mutation admitted to the Pediatric Endocrinology Department of Sun Yat-sen Memorial Hospital in April 2017,and then conducted a comparative analysis with relevant literature.[Results]The 2.9-year-old boy at initial visit was born prematurely at 36 weeks of gestation,with a birth weight of 1.7 kg and a body length of 42.0 cm.Clinical manifestations included intrauterine growth retardation,delayed language and motor development,extreme short stature(82.0 cm,-3.7 SD),emaciation,and distinctive facial features(triangular face,narrow jaw,prominent forehead,arched eyebrows,sparse eyebrows,high anterior hairline,crowded dentition),accompanied by bilateral cryptorchidism.Bone age was delayed by 1.4 years.Karyotyping and chromosomal microarray analysis were normal.GH therapy initiated at 3.8 years old yielded annual growth rates of 4.9-6.6 cm/year.When the treatment was discontinued at the age of 8.0,the boy's height was 113.7 cm(-3.0 SD),with subsequent decline in growth velocity.Whole exome sequencing in July 2024 identified a frameshift variant c.4028del(p.Pro1343Glnfs*49)in NSD2,which was confirmed as de novo pathogenic variation by parental Sanger sequencing.[Conclusions]This study reports the clinical features of RAUST syndrome caused by NSD2 mutation and explores the long-term efficacy of GH therapy.The findings contribute to a better understanding of this rare syndrome and further optimize its diagnosis and management.
4.Role and mechanism of DPP4-nestin axis in liver fibrosis induced by Echinococcus alveolar infection
Jin GAO ; Tao SUN ; Mulati MUKEXINA ; Xiaolong HE ; Jing SHI ; Liang LI ; Ning YANG ; Jin CHU ; Xue ZHANG ; Hui LIU ; Guodong LYU ; Renyong LIN ; Xiaojuan BI ; Qingyong GUO
Chinese Journal of Veterinary Science 2025;45(2):298-304
To investigate the role of the DPP4-nestin axis in liver fibrosis induced by alveolar cyst infection,a murine model was established using C57BL/6 mice via hepatic portal vein injection.Liver histopathological changes were assessed using HE staining,while immunohistochemistry and immunofluorescence were employed to evaluate the expression levels of nestin and DPP4 in infected mouse livers.In vitro,J S1 cell line was stimulated with recombinant DPP4 protein to es-tablish a cellular model,and qPCR,Western blot,and shRNA lentivirus interference techniques were utilized to examine the involvement of the DPP4-nestin axis in hepatic stellate cell activation.The findings demonstrated that compared to the Sham group,liver tissue structure disruption and collagen deposition were evident along with significantly increased expressions of nestin and DPP4(P<0.050 0),which colocalized with nesin and α-SMA.Furthermore,stimulation with recombi-nant DPP4 protein significantly enhanced JS1 cell activation(P<0.050 0)as well as upregulated nestin expression(P<0.050 0)when compared to control group cells.Notably,shRNA lentivirus-mediated inhibition of nestin expression effectively suppressed the activating effects exerted by re-combinant DPP4 protein on JS1 cells(P<0.050 0).Collectively,these results highlight the crucial regulatory role played by the DPP4-nestin axis in hepatic stellate cell activation triggered by alveo-lar infection;thus,targeting this axis may represent a novel therapeutic strategy for treating alveo-lar infection-induced liver fibrosis.
5.Clinical manifestations of medically refractory hereditary movement disorders in children and efficacy of deep brain stimulation
Lifang DAI ; Tinghong LIU ; Feng ZHAI ; Anna ZHOU ; Qiuhong WANG ; Zihang XIE ; Xiaojuan TIAN ; Xu WANG ; Shuli LIANG ; Hui XIONG ; Changhong DING
Chinese Journal of Applied Clinical Pediatrics 2025;40(7):526-532
Objective:To investigate the clinical manifestations of medically refractory hereditary movement disorders in children and the efficacy of deep brain stimulation (DBS).Methods:A case series study.The clinical and follow-up data of 20 children with medically refractory hereditary movement disorders who underwent DBS treatment at the Neurology and Functional Neurosurgery Departments of Beijing Children′s Hospital, Capital Medical University, from July 2018 to April 2024, were retrospectively analyzed.The severity of movement disorder symptoms and surgical effects were evaluated using the Burke-Fahn-Marsden Dystonia Rating Scale Movement(BFMDRS-M) or the Unified Parkinson′s Disease Rating Scale Ⅲ(UPDRS Ⅲ).Results:There were 12 males and 8 females among the 20 children, with an onset age ranging from 4 months to 12 years and 5 months.Fourteen patients had hereditary dystonia, which is related to KMT2B in 11 patients, TOR1A in 2 patients and SGCE in 1 patient.Two patients had choreoathetosis, which is related to ADCY5-related familial movement disorders.Two patients had early-onset Parkinson′s disease, which is related to ATP6AP2 in 1 patient and VPS13C in 1 patient.Two patients had neurodevelopmental disorders with involuntary movements, which is related to GNAO1 in 1 patient, and the other patient was idiopathic.All the children were given oral Levodopa, Benzhexol, Baclofen, Tiapride Hydrochloride, Clonazepam alone or in combination.Three children showed obvious dyskinesia after Levodopa treatment.The symptoms of movement disorders in all children exhibited little to no improvement.Levetiracetam and Zonisamide had unstable effects in the treatment of myoclonia.DBS surgery was performed on all the patients aged from 3 to 16 years.Electrodes were successfully inserted into bilateral globus pallidus internus in 14 cases and bilateral subthalamic nuclei in 4 cases.The target was unknown in 2 cases.No surgery-related complications were observed.The patients were followed up for 3 months to 6 years, and the last follow-up age of the patients ranged from 5 years and 7 months to 22 years and 1 month.The rate of improvement in BFMDRS-M score was 37%-100% in 16 patients and >70% in 7 patients with hereditary dystonia.The rate of improvement in UPDRS Ⅲ score was 23% in 1 patient with VPS13C-related early-onset Parkinson′s disease. Conclusions:Childhood medically refractory hereditary movement disorders are a case series that exhibits significant phenotypic and genotypic heterogeneity.DBS surgery demonstrates significant efficacy for KMT2B-, TOR1A-, and SGCE-related hereditary movement disorders.
6.Evaluation on the Efficacy and Advantages and Mechanisms of TCM in Preventing and Treating"Inflammation-cancer Transformation"of Colorectal Adenoma-colorectal Cancer
Xiaojuan TANG ; Yuan REN ; Min HE ; Liang ZHAO ; Yuan LYU ; Yongmin LI ; Jing HUANG ; Yongheng HE
Chinese Journal of Information on Traditional Chinese Medicine 2025;32(2):20-24
Colorectal adenoma is a definite precancerous lesion,and the"inflammation-cancer transformation"is a key pathological link in the process of colorectal adenoma-cancer evolution.Under the guidance of the theory of"preventive treatment of diseases"in TCM,prevention before disease onset and preventing the development of the occurred disease has become the consensus and the important subject of clinical research to block the"inflammation-cancer transformation"and prevent the precancerous lesions of colorectal cancer.This article discussed the effectiveness of TCM in preventing and treating the"inflammation-cancer transformation"from different aspects.Its advantages are reflected in improving the symptoms of TCM and improving the quality of life,etc.Its mechanism may be related to inhibiting the activation of cancer-promoting signals,regulating inflammation,maintaining intestinal microbial homeostasis,and protecting the intestinal barrier.By explaining the pathogenesis of adenoma-cancer transformation in TCM,this article discussed the efficacy and advantages of TCM to block"inflammation-cancer transformation",analyzed its intervention targets and pathways,providing references for the intervention of TCM in the management of precancerous lesions of colorectal cancer and the synergistic prevention and treatment of traditional Chinese and Western medicine.
7.Interpretation for the General Chapter 0237 the preparation and establishment of national biological reference standards in Chinese Pharmacopoeia 2025 Edition Volume Ⅲ
WANG Yiping ; MAO Qunying ; WANG Xiaojuan ; LIANG Zhenglun
Drug Standards of China 2025;26(1):099-104
The Chinese Pharmacopoeia 2025 Edition is about to be officially released. Based on multiple meetings and extensive consultations the vaccine products professional committee of the 12th pharmacopoeia commission, has revised and formed the general chapter 0237 for the preparation of national biological reference standards in Chinese Pharmacopoeia 2025 Edition volume Ⅲ. General chapter 0237, integrating the cutting-edge concepts from WHO’s related guidelines and the practical experience of biological reference standards both domestically, has revised the names of this chapter, updated and improved the technical requirements for candidate reference materials, collaborative calibration and value assignment, as well as stability research and monitoring. It also newly proposes the calculation of uncertainty of biological reference materials and emphasizes to pay attention to commutability. The implementation of general chapter 0237 will play a guiding role in improving the research and application level of biological reference materials in China. This article, by interpreting the revised content of general chapter 0237, aims to provide a reference for the researchers of biological reference materials.
8.Interpretation for the General Chapter 0237 the preparation and establishment of national biological reference standards in Chinese Pharmacopoeia 2025 Edition Volume Ⅲ
Yiping WANG ; Qunying MAO ; Xiaojuan WANG ; Zhenglun LIANG
Drug Standards of China 2025;26(1):99-104
The Chinese Pharmacopoeia 2025 Edition is about to be officially released.Based on multiple meetings and extensive consultations the vaccine products professional committee of the 12th pharmacopoeia commission,has revised and formed the general chapter 0237 for the preparation of national biological reference standards in Chinese Pharmacopoeia 2025 Edition volume Ⅲ.General chapter 0237,integrating the cutting-edge concepts from WHO's related guidelines and the practical experience of biological reference standards both domestically,has revised the names of this chapter,updated and improved the technical requirements for candidate reference materials,collabo-rative calibration and value assignment,as well as stability research and monitoring.It also newly proposes the cal-culation of uncertainty of biological reference materials and emphasizes to pay attention to commutability.The im-plementation of general chapter 0237 will play a guiding role in improving the research and application level of bio-logical reference materials in China.This article,by interpreting the revised content of general chapter 0237,aims to provide a reference for the researchers of biological reference materials.
9.Evaluation on the Efficacy and Advantages and Mechanisms of TCM in Preventing and Treating"Inflammation-cancer Transformation"of Colorectal Adenoma-colorectal Cancer
Xiaojuan TANG ; Yuan REN ; Min HE ; Liang ZHAO ; Yuan LYU ; Yongmin LI ; Jing HUANG ; Yongheng HE
Chinese Journal of Information on Traditional Chinese Medicine 2025;32(2):20-24
Colorectal adenoma is a definite precancerous lesion,and the"inflammation-cancer transformation"is a key pathological link in the process of colorectal adenoma-cancer evolution.Under the guidance of the theory of"preventive treatment of diseases"in TCM,prevention before disease onset and preventing the development of the occurred disease has become the consensus and the important subject of clinical research to block the"inflammation-cancer transformation"and prevent the precancerous lesions of colorectal cancer.This article discussed the effectiveness of TCM in preventing and treating the"inflammation-cancer transformation"from different aspects.Its advantages are reflected in improving the symptoms of TCM and improving the quality of life,etc.Its mechanism may be related to inhibiting the activation of cancer-promoting signals,regulating inflammation,maintaining intestinal microbial homeostasis,and protecting the intestinal barrier.By explaining the pathogenesis of adenoma-cancer transformation in TCM,this article discussed the efficacy and advantages of TCM to block"inflammation-cancer transformation",analyzed its intervention targets and pathways,providing references for the intervention of TCM in the management of precancerous lesions of colorectal cancer and the synergistic prevention and treatment of traditional Chinese and Western medicine.
10.Rauch-Steindl Syndrome Caused by NSD2 Mutation:A Case Report and Follow-up of Growth Hormone Therapy
Qun ZENG ; Siqi HUANG ; Hui OU ; Xiaojuan LI ; Liyang LIANG
Journal of Sun Yat-sen University(Medical Sciences) 2025;46(4):714-720
[Objective]To analyze the clinical characteristics,efficacy of growth hormone(GH)therapy,and follow-up of a child with Rauch-Steindl syndrome(RAUST)caused by NSD2 gene mutation,aiming to enhance pediatricians'understanding of this disorder.[Methods]We summarized the clinical features,gene test results,outcomes of GH therapy,and follow-up data of a child with RAUST syndrome caused by NSD2 mutation admitted to the Pediatric Endocrinology Department of Sun Yat-sen Memorial Hospital in April 2017,and then conducted a comparative analysis with relevant literature.[Results]The 2.9-year-old boy at initial visit was born prematurely at 36 weeks of gestation,with a birth weight of 1.7 kg and a body length of 42.0 cm.Clinical manifestations included intrauterine growth retardation,delayed language and motor development,extreme short stature(82.0 cm,-3.7 SD),emaciation,and distinctive facial features(triangular face,narrow jaw,prominent forehead,arched eyebrows,sparse eyebrows,high anterior hairline,crowded dentition),accompanied by bilateral cryptorchidism.Bone age was delayed by 1.4 years.Karyotyping and chromosomal microarray analysis were normal.GH therapy initiated at 3.8 years old yielded annual growth rates of 4.9-6.6 cm/year.When the treatment was discontinued at the age of 8.0,the boy's height was 113.7 cm(-3.0 SD),with subsequent decline in growth velocity.Whole exome sequencing in July 2024 identified a frameshift variant c.4028del(p.Pro1343Glnfs*49)in NSD2,which was confirmed as de novo pathogenic variation by parental Sanger sequencing.[Conclusions]This study reports the clinical features of RAUST syndrome caused by NSD2 mutation and explores the long-term efficacy of GH therapy.The findings contribute to a better understanding of this rare syndrome and further optimize its diagnosis and management.

Result Analysis
Print
Save
E-mail